Table 1.
Comparison of fundamental clinical parameters in HT group versus non-ht group.
| Characteristics | HT (n = 65) | Non-HT (n = 63) | p value |
|---|---|---|---|
| Age (years) Sex, male Alcohol consumption Smoking BMI (kg/m2) |
42.2 ± 12.1 14 (21.54) 10 (15.38) 12 (18.46) 23.25 ± 2.40 |
48.6 ± 14.5 17 (26.98) 18 (28.57) 25 (39.68) 21.61 ± 3.21 |
0.827 0.539 0.088 0.011 0.032 |
| Pre-existing morbidities | |||
| Hypertension Diabetes Stroke Covid-19 vaccines received |
12 (18.46) 10 (15.38) 5 (7.69) 44 (67.69) |
24 (38.10) 14 (22.22) 11 (17.46) 54 (85.71) |
0.018 0.370 0.114 0.016 |
| Covid-19 Infected symptoms | |||
| Fever (>38°C) Dyspnea Diarrhea Sore throat Cough Muscle pain Loss of taste or smell Tachycardia |
27 (21.09) 11 (57.89) 21 (16.41) 26 (20.31) 36 (55.38) 19 (29.23) 10 (15.38) 5 (8.97) |
20 (15.63) 8 (12.70) 23 (17.97) 13 (10.16) 21 (33.33) 9 (14.29) 8 (12.70) 2 (3.17) |
0.276a 0.621a 0.710a 0.021a 0.014a 0.156a 0.801a 0.440a |
This table compares the fundamental clinical characteristics and COVID-19 infected systems of patients in two groups (HT group versus non-HT group). Significant p values are indicated in bold. Data are presented as mean ± SD, median (IQR), number (%) as appropriate.
aCovid-19 vaccines received status is adjusted.
Abbreviations: HT, Hashimoto’s Thyroiditis; non-HT, not Hashimoto’s Thyroiditis; BMI, body mass index.